Gan & Lee Pharmaceuticals Subsidiary Secures ANVISA Sterile Preparation GMP Certification in Brazil

Stock News05-26

Gan & Lee Pharmaceuticals (603087.SH) has announced that its subsidiary, Gan & Lee Pharmaceuticals Brazil Trading and Pharmaceutical Import Co., Ltd., recently received a Good Manufacturing Practice (GMP) certification issued by the Brazilian Health Regulatory Agency (ANVISA). The successful acquisition of this sterile preparation GMP certification from ANVISA indicates that the company's manufacturing facilities, equipment, and infrastructure comply with Brazilian GMP standards. This achievement lays a solid foundation for the company to further expand its presence in the Brazilian market and other international markets, representing a positive step forward in the implementation of its internationalization strategy.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment